| Rania Mokbel Dahabreh, MD | |
|
600 N.wolfe St, The Wilmer Institute , 233 Johns Hopkins Hospital, Baltimore, MD 21287-9028 | |
| (410) 955-8314 | |
| (410) 955-0809 |
| Full Name | Rania Mokbel Dahabreh |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 600 N.wolfe St, Baltimore, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760675243 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 22276 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rania Mokbel Dahabreh, MD 600 N Wolfe St, The Wilmer Institute, 233 Johns Hopkins Hospital, Baltimore, MD 21287-0005 Ph: (410) 955-8314 | Rania Mokbel Dahabreh, MD 600 N.wolfe St, The Wilmer Institute , 233 Johns Hopkins Hospital, Baltimore, MD 21287-9028 Ph: (410) 955-8314 |
News Archive
Efforts to correct false beliefs about health care reform may backfire, depending on individuals' political views and level of knowledge, suggests a study in the February issue of Medical Care.
After the State Department released recommendations for how to improve its own effectiveness and that of USAID in last week's Quadrennial Diplomacy and Development Review (QDDR), the Kaiser Daily Global Health Policy Report's Jaclyn Schiff spoke with Jennifer Kates, vice president and director of Global Health Policy & HIV at the Kaiser Family Foundation, about the QDDR in relation to U.S. global health efforts.
Around half of patients receive radiotherapy as part of their cancer treatment but the dose is limited by the possibility of causing side effects (toxicity) to the normal tissues and organs that surround the tumour.
TissueGene, Inc. today reported that the U.S. Food and Drug Administration (FDA) accepted the proposed brand name Invossa for TissueGene-C, the Company's proprietary product in development for treatment of osteoarthritis of the knee. FDA's acceptance of the proprietary brand name is subject to the Agency's final determination prior to any approval of the product's Biologic License Application (BLA) and market launch.
Every 30 seconds, infectious diseases such as malaria, HIV/AIDS and tuberculosis kill as many people as Jack the Ripper did in his entire career. New research published in BioMed Central's open access journal International Journal of Health Geographics demonstrates how the mathematical model of geographic profiling, used in the hunt for serial killers, can help combat infectious diseases.
› Verified 7 days ago
Dr. Pradeep Y Ramulu, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-6052 | |
Ashley Behrens, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 N. Wolfe Street, Baltimore, MD 21287 Phone: 410-502-0461 | |
Neil R Miller, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-5080 | |
Dr. Allan Griffiths Scott, M.D Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 6231 N Charles St, Baltimore, MD 21212 Phone: 410-377-2044 Fax: 410-377-8061 | |
Lily T Im, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 419 W Redwood St, Suite 479, Baltimore, MD 21201 Phone: 410-328-5918 Fax: 410-328-6346 | |
Brinda Muthusamy, MBCHB Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: The Wilmer Eye Institute Johns, 600 North Wolfe Street, Baltimore, MD 21287 Phone: 410-955-8314 | |
Israel Jesus Mendez, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 600 N Wolfe St, Baltimore, MD 21264 Phone: 410-955-5080 |